XML 53 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Parent Only Financial Information
12 Months Ended
Dec. 31, 2023
Parent Only Financial Information [Abstract]  
PARENT ONLY FINANCIAL INFORMATION

NOTE 26 PARENT ONLY FINANCIAL INFORMATION

 

The Company performed a test on the restricted net assets of consolidated subsidiaries in accordance with Securities and Exchange Commission Regulation S-X Rule 5-04 and concluded that it was applicable for the Company to disclose the financial statements for AGBA Group Holding Limited, the parent company.

 

The Company did not have significant capital and other commitments, long-term obligations, or guarantees as of December 31, 2023 and 2022. Certain information and footnote disclosures generally included in financial statements prepared in accordance with U.S. GAAP have been condensed and omitted.

 

The following presents condensed parent company only financial information of AGBA Group Holding Limited.

 

Condensed balance sheets

 

  As of December 31, 
   2023   2022 
ASSETS        
Current assets:        
Cash and cash equivalents  $129,660   $85,955 
Restricted cash   
    15,356,580 
Amounts due from the holding company   133,070    
 
Amounts due from subsidiaries   

908,811

     
Deposit, prepayments, and other receivables   453,620    1,715 
Total current assets   1,625,161    15,444,250 
           
Non-current assets:          
Investments in subsidiaries   13    13 
Total non-current assets   13    13 
           
TOTAL ASSETS  $1,625,174   $15,444,263 
           
LIABILITIES AND SHAREHOLDERS’ DEFICIT          
Current liabilities:          
Other payable and accrued liabilities  $3,738,639   $6,577,351 
Amounts due to subsidiaries   13    13 
Amounts due to the related companies   
    1,327,107 
Forward share purchase liability   
    13,491,606 
Total current liabilities   3,738,652    21,396,077 
           
Long-term liabilities:          
Warrant liabilities   
    4,548 
Total long-term liabilities   
    4,548 
           
TOTAL LIABILITIES   3,738,652    21,400,625 
           
Commitments and contingencies (Note 24)   
 
    
 
 
           
Shareholders’ deficit:          
Ordinary shares, $0.001 par value; 200,000,000 shares authorized, 68,661,998 and 58,376,985 shares issued and outstanding as of December 31, 2023 and 2022, respectively   68,662    58,377 
Ordinary shares to be issued   4,854    1,665 
Additional paid-in capital   19,507,136    1,867,335 
Accumulated deficit   (21,694,130)   (7,883,739)
Total shareholders’ deficit   (2,113,478)   (5,956,362)
           
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT  $1,625,174   $15,444,263 

 

Condensed Statements of Operations

 

  For the years ended
December 31,
 
   2023   2022 
Operating cost and expenses:        
Share-based compensation expense  $(9,932,762)  $(2,088,725)
Other general and administrative expenses   (3,764,618)   (479,407)
Total operating cost and expenses   (13,697,380)   (2,568,132)
           
Loss from operations   (13,697,380)   (2,568,132)
           
Other income (expense):          
Change in fair value of warrant liabilities   4,548    8,952 
Change in fair value of forward share purchase liability   (82,182)   (5,392,293)
Loss on settlement of forward share purchase agreement   (378,895)   
 
Sundry income   343,518    67,734 
Total other expense, net   (113,011)   (5,315,607)
           
Loss before income taxes   (13,810,391)   (7,883,739)
           
Income tax expense   
    
 
           
NET LOSS  $(13,810,391)  $(7,883,739)

 

Condensed Statement of Cash Flows

 

  For the years ended
December 31,
 
   2023   2022 
Cash flows from operating activities:        
Net loss  $(13,810,391)  $(7,883,739)
Adjustments to reconcile net loss to net cash used in operating activities          
Share-based compensation expense   9,932,762    2,088,725 
Change in fair value of warrant liabilities   (4,548)   (8,952)
Change in fair value of forward share purchase liability   82,182    5,392,293 
Loss on settlement of forward share purchase agreement   378,895    
 
           
Change in operating assets and liabilities:          
Deposits, prepayments, and other receivables   (17,035)   (1,715)
Other payables and accrued liabilities   1,161,288    (839,181)
Net cash used in operating activities   (2,276,847)   (1,252,569)
           
Cash flows from financing activities:          
(Repayment to) advances from related companies   (933,655)   1,338,524 
Settlement of forward share purchase agreement   (13,952,683)   
 
Proceeds from private placement   1,850,310    
 
Cash proceeds from reverse recapitalization, net of redemption   
    15,356,580 
Net cash (used in) provided by financing activities   (13,036,028)   16,695,104 
           
Net change in cash, cash equivalent and restricted cash   (15,312,875)   15,442,535 
           
BEGINNING OF YEAR   15,442,535    
 
           
END OF YEAR  $129,660   $15,442,535 
           

 

    

As of December 31,

 
    2023    2022 
Reconciliation to amounts on consolidated balance sheets:          
Cash and cash equivalents  $129,660   $85,955 
Restricted cash   
    15,356,580 
           
Total cash, cash equivalents and restricted cash  $129,660   $15,442,535